Patient Characteristics and Persistence Among Commercially Insured Patients With Multiple Sclerosis Initiating Cladribine Tablets

被引：0
|
作者：
Kozma, Chris [1 ]
Evans, Emily [2 ]
Lebson, Lori [2 ]
Phillips, Amy [2 ]
Lobo, Carroline [2 ]
机构：
[1] CK Consulting Associates LLC, Baton Rouge, LA USA
[2] EMD Serono Inc, Rockland, MA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203948
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P14-3.001
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Recommendations for the use of cladribine tablets in recurring multiple sclerosis
    Oreja-Guevara, Celia
    Garcia-Merino, Juan A.
    Saiz, Albert
    Rodriguez-Antiguedad, Alfredo
    Alvarez-Cermeno, Jose C.
    Estrada-Perez, Vicente
    Izquierdo, Guillermo
    Fernandez, Oscar
    REVISTA DE NEUROLOGIA, 2019, 69 : S1 - S9
  • [22] Cladribine tablets and multiple sclerosis: NICE technology appraisal
    Gaber, Tarek
    Shippen, Clare
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2018, 22 (01) : 5 - 6
  • [23] Cladribine Tablets In Relapsing-Remitting Multiple Sclerosis
    Muir, Victoria J.
    Plosker, Greg L.
    CNS DRUGS, 2011, 25 (03) : 239 - 249
  • [24] Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study
    Rauma, Ilkka
    Viitala, Matias
    Kuusisto, Hanna
    Atula, Sari
    Sipila, Jussi O. T.
    Ryytty, Mervi
    Soilu-Hanninen, Merja
    Jarvinen, Elina
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 61
  • [25] COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update
    Jack, Dominic
    Damian, Doris
    Nolting, Axel
    Galazka, Andrew
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [26] Real-world use of cladribine tablets (Completion rates and treatment persistence) In patients with multiple sclerosis in England: the CLARENCE Study
    Brownlee, W.
    Amin, A.
    Ashton, L.
    Herbert, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 666 - 667
  • [27] Clinical and Radiologic Outcomes in Medicaid versus Commercially Insured Multiple Sclerosis Patients
    Osen, Allison
    Morales, Fabian Sierra
    Kubicki, Konrad
    Johnson, Tricia
    Oyuang, Bichun
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 775 - 776
  • [28] Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: The CLARENCE study
    Brownlee, Wallace
    Amin, Amerah
    Ashton, Luke
    Herbert, Alex
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [29] Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States
    Zhou, Zhou
    Fan, Yanni
    Tang, Wenxi
    Liu, Xinyue
    Thomason, Darren
    Zhou, Zheng-Yi
    Macaulay, Dendy
    Fischer, Aryeh
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) : 920 - 927
  • [30] Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
    Dai, Dingwei
    Sharma, Ajay
    Phillips, Amy L.
    Lobo, Carroline
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (02): : 125 - 133
12345